Role of Oxygen Starvation in Right Ventricular Decompensation and Failure in Pulmonary Arterial Hypertension

被引:3
|
作者
Okninska, Marta [1 ]
Zajda, Karolina [2 ]
Zambrowska, Zuzanna [1 ]
Grzanka, Malgorzata [3 ]
Paterek, Aleksandra [1 ]
Mackiewicz, Urszula [1 ]
Szczylik, Cezary [4 ]
Kurzyna, Marcin [5 ]
Piekielko-Witkowska, Agnieszka [3 ]
Torbicki, Adam [5 ]
Kieda, Claudine [2 ,6 ,7 ]
Maczewski, Michal [1 ]
机构
[1] Ctr Postgrad Med Educ, Dept Clin Physiol, Marymoncka Str 99-103, PL-01813 Warsaw, Poland
[2] Mil Med Inst, Lab Mol Oncol & Innovat Therapies, Warsaw, Poland
[3] Ctr Postgrad Med Educ, Dept Biochem & Mol Biol, Warsaw, Poland
[4] Ctr Postgrad Med Educ, Dept Oncol ECZ Otwock, Warsaw, Poland
[5] Ctr Postgrad Med Educ, Dept Pulm Circulat Thromboembol Dis & Cardiol ECZ, Warsaw, Poland
[6] Ctr Mol Biophys, UPR, CNRS 4301, Orleans, France
[7] Ctr Postgrad Med Educ, Dept Mol & Translat Oncol, Warsaw, Poland
关键词
angiogenesis; hypertrophy; oxygen deficiency; pulmonary arterial hypertension; right ventricular failure;
D O I
10.1016/j.jchf.2023.03.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Right ventricular (RV) function and eventually failure determine outcome in patients with pulmonary arterial hypertension (PAH). Initially, RV responds to an increased load caused by PAH with adaptive hypertrophy; however, eventually RV failure ensues. Unfortunately, it is unclear what causes the transition from compensated RV hypertrophy to decompensated RV failure. Moreover, at present, there are no therapies for RV failure; those for left ventricular (LV) failure are ineffective, and no therapies specifically targeting RV are available. Thus there is a clear need for understanding the biology of RV failure and differences in physiology and pathophysiology between RV and LV that can ultimately lead to development of such therapies. In this paper, we discuss RV adaptation and maladaptation in PAH, with a particular focus of oxygen delivery and hypoxia as the principal drivers of RV hypertrophy and failure, and attempt to pinpoint potential sites for therapy. (J Am Coll Cardiol HF 2024;12:235-247) (c) 2024 by the American College of Cardiology Foundation.
引用
收藏
页码:235 / 247
页数:13
相关论文
共 50 条
  • [41] The Right Ventricle in Pulmonary Arterial Hypertension Disorders of Metabolism, Angiogenesis and Adrenergic Signaling in Right Ventricular Failure
    Ryan, John J.
    Archer, Stephen L.
    CIRCULATION RESEARCH, 2014, 115 (01) : 176 - 188
  • [42] Right Ventricular Functional Reserve in Pulmonary Arterial Hypertension
    Hsu, Steven
    Houston, Brian A.
    Tampakakis, Emmanouil
    Bacher, Anita C.
    Rhodes, Parker S.
    Mathai, Stephen C.
    Damico, Rachel L.
    Kolb, Todd M.
    Hummers, Laura K.
    Shah, Ami A.
    McMahan, Zsuzsanna
    Corona-Villalobos, Celia P.
    Zimmerman, Stefan L.
    Wigley, Fredrick M.
    Hassoun, Paul M.
    Kass, David A.
    Tedford, Ryan J.
    CIRCULATION, 2016, 133 (24) : 2413 - +
  • [43] Right ventricular assist device use in ventricular failure due to pulmonary arterial hypertension: Lessons learned
    Rosenzweig, Erika B.
    Chicotka, Scott
    Bacchetta, Matthew
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (10): : 1272 - 1274
  • [44] Pulmonary hypertension and right ventricular failure. Part X. Prostanoids in the treatment of primary pulmonary arterial hypertension
    Batyraliev, T. A.
    Makhmutkhodzhaev, S. A.
    Ekinci, E.
    Pataraya, S. A.
    Pershukov, I. V.
    Sidorenko, B. A.
    Preobrazhensky, D. V.
    KARDIOLOGIYA, 2007, 47 (06) : 70 - 77
  • [45] Role for Mir-126 in Right Ventricle Failure in Pulmonary Arterial Hypertension
    Potus, Francois
    Malenfant, Simon
    Bonnet, Sandra Breuils
    Paulin, Roxane
    Ferrero, Pasquale
    Michelakis, Evangelos
    Provencher, Steeve
    Bonnet, Sebastien
    CIRCULATION, 2014, 130
  • [46] Pulmonary hypertension and right ventricular failure. Part V. Classification and pathomorphology of primary pulmonary arterial hypertension
    Batyraliev, T. A.
    Makhmutkhodzhaev, S. A.
    Ecinci, E.
    Pataraya, S. A.
    Pershukov, I. V.
    Sidorenko, B. A.
    Preobrazhensky, D. V.
    KARDIOLOGIYA, 2007, 47 (01) : 75 - 81
  • [47] The role of the right ventricle in pulmonary arterial hypertension
    Noordegraaf, A. Vonk
    Galie, N.
    EUROPEAN RESPIRATORY REVIEW, 2011, 20 (122): : 243 - 253
  • [48] Role Of PKM2 and Oxidative DNA Damage in the Pathogenesis of Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
    Shimauchi, Tsukasa
    Omura, Junichi
    Bonnet, Sandra B.
    Paulin, Roxane
    Provencher, Steeve
    Boucherat, Olivier
    Bonnet, Sebastien
    CIRCULATION, 2019, 140
  • [49] Role of Parp1-pkm2 Axis in the Pathogenesis of Right Ventricular Failure Associated With Pulmonary Arterial Hypertension
    Shimauchi, Tsukasa
    Omura, Junichi
    Bonnet, Sandra Breuils
    Nadeau, Valerie
    Tremblay, Eve
    Grobs, Yann
    Potus, Francois
    Paulin, Roxane
    Provencher, Steeve
    Boucherat, Olivier
    Bonnet, Sebastien
    CIRCULATION, 2020, 142
  • [50] Sex Differences in Right Ventricular-Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension
    Tello, Khodr
    Richter, Manuel J.
    Yogeswaran, Athithan
    Ghofrani, Hossein A.
    Naeije, Robert
    Vanderpool, Rebecca
    Gall, Henning
    Tedford, Ryan J.
    Seeger, Werner
    Lahm, Tim
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (07) : 1042 - 1046